Thymosin β4 is cardioprotective after myocardial infarction

Deepak Srivastava, Ankur Saxena, J. Michael Dimaio, Ildiko Bock-Marquette

Research output: Chapter in Book/Report/Conference proceedingConference contribution

35 Citations (Scopus)

Abstract

Heart disease is a leading cause of death in newborns and in adults. Efforts to promote cardiac repair by introduction or recruitment of exogenous stem cells hold promise but typically involve isolation and introduction of autologous or donor progenitor cells. We have found that the G-actin-sequestering peptide thymosin β4 promotes myocardial and endothelial cell migration in the embryonic heart and retains this property in postnatal cardiomyocytes. Survival of embryonic and postnatal cardiomyocytes in culture was also enhanced by thymosin β4. We found that thymosin β4 formed a functional complex with PINCH and integrin-linked kinase (ILK), resulting in activation of the survival kinase Akt/PKB, which was necessary for thymosin β4's effects on cardiomyocytes. After coronary artery ligation in mice, thymosin β4 treatment resulted in upregulation of ILK and Akt activity in the heart, enhanced early myocyte survival, and improved cardiac function. These findings suggest that thymosin β4 promotes cardiomyocyte and endothelial migration, survival, and repair and may be a novel therapeutic target in the setting of acute myocardial damage.

Original languageEnglish (US)
Title of host publicationAnnals of the New York Academy of Sciences
Pages161-170
Number of pages10
Volume1112
DOIs
StatePublished - Sep 2007

Publication series

NameAnnals of the New York Academy of Sciences
Volume1112
ISSN (Print)00778923
ISSN (Electronic)17496632

Fingerprint

Thymosin
Myocardial Infarction
Cardiac Myocytes
Repair
Stem Cells
Endothelial cells
Stem cells
Muscle Cells
Cell Movement
Ligation
Actins
Cause of Death
Heart Diseases
Coronary Vessels
Phosphotransferases
Up-Regulation
Endothelial Cells
Chemical activation
Peptides

Keywords

  • Cardiac repair
  • Integrin-linked kinase
  • Thymosin β4

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Srivastava, D., Saxena, A., Dimaio, J. M., & Bock-Marquette, I. (2007). Thymosin β4 is cardioprotective after myocardial infarction. In Annals of the New York Academy of Sciences (Vol. 1112, pp. 161-170). (Annals of the New York Academy of Sciences; Vol. 1112). https://doi.org/10.1196/annals.1415.048

Thymosin β4 is cardioprotective after myocardial infarction. / Srivastava, Deepak; Saxena, Ankur; Dimaio, J. Michael; Bock-Marquette, Ildiko.

Annals of the New York Academy of Sciences. Vol. 1112 2007. p. 161-170 (Annals of the New York Academy of Sciences; Vol. 1112).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Srivastava, D, Saxena, A, Dimaio, JM & Bock-Marquette, I 2007, Thymosin β4 is cardioprotective after myocardial infarction. in Annals of the New York Academy of Sciences. vol. 1112, Annals of the New York Academy of Sciences, vol. 1112, pp. 161-170. https://doi.org/10.1196/annals.1415.048
Srivastava D, Saxena A, Dimaio JM, Bock-Marquette I. Thymosin β4 is cardioprotective after myocardial infarction. In Annals of the New York Academy of Sciences. Vol. 1112. 2007. p. 161-170. (Annals of the New York Academy of Sciences). https://doi.org/10.1196/annals.1415.048
Srivastava, Deepak ; Saxena, Ankur ; Dimaio, J. Michael ; Bock-Marquette, Ildiko. / Thymosin β4 is cardioprotective after myocardial infarction. Annals of the New York Academy of Sciences. Vol. 1112 2007. pp. 161-170 (Annals of the New York Academy of Sciences).
@inproceedings{3babdcf435cf4c91b48e05a7e2ba3f4e,
title = "Thymosin β4 is cardioprotective after myocardial infarction",
abstract = "Heart disease is a leading cause of death in newborns and in adults. Efforts to promote cardiac repair by introduction or recruitment of exogenous stem cells hold promise but typically involve isolation and introduction of autologous or donor progenitor cells. We have found that the G-actin-sequestering peptide thymosin β4 promotes myocardial and endothelial cell migration in the embryonic heart and retains this property in postnatal cardiomyocytes. Survival of embryonic and postnatal cardiomyocytes in culture was also enhanced by thymosin β4. We found that thymosin β4 formed a functional complex with PINCH and integrin-linked kinase (ILK), resulting in activation of the survival kinase Akt/PKB, which was necessary for thymosin β4's effects on cardiomyocytes. After coronary artery ligation in mice, thymosin β4 treatment resulted in upregulation of ILK and Akt activity in the heart, enhanced early myocyte survival, and improved cardiac function. These findings suggest that thymosin β4 promotes cardiomyocyte and endothelial migration, survival, and repair and may be a novel therapeutic target in the setting of acute myocardial damage.",
keywords = "Cardiac repair, Integrin-linked kinase, Thymosin β4",
author = "Deepak Srivastava and Ankur Saxena and Dimaio, {J. Michael} and Ildiko Bock-Marquette",
year = "2007",
month = "9",
doi = "10.1196/annals.1415.048",
language = "English (US)",
isbn = "1573317012",
volume = "1112",
series = "Annals of the New York Academy of Sciences",
pages = "161--170",
booktitle = "Annals of the New York Academy of Sciences",

}

TY - GEN

T1 - Thymosin β4 is cardioprotective after myocardial infarction

AU - Srivastava, Deepak

AU - Saxena, Ankur

AU - Dimaio, J. Michael

AU - Bock-Marquette, Ildiko

PY - 2007/9

Y1 - 2007/9

N2 - Heart disease is a leading cause of death in newborns and in adults. Efforts to promote cardiac repair by introduction or recruitment of exogenous stem cells hold promise but typically involve isolation and introduction of autologous or donor progenitor cells. We have found that the G-actin-sequestering peptide thymosin β4 promotes myocardial and endothelial cell migration in the embryonic heart and retains this property in postnatal cardiomyocytes. Survival of embryonic and postnatal cardiomyocytes in culture was also enhanced by thymosin β4. We found that thymosin β4 formed a functional complex with PINCH and integrin-linked kinase (ILK), resulting in activation of the survival kinase Akt/PKB, which was necessary for thymosin β4's effects on cardiomyocytes. After coronary artery ligation in mice, thymosin β4 treatment resulted in upregulation of ILK and Akt activity in the heart, enhanced early myocyte survival, and improved cardiac function. These findings suggest that thymosin β4 promotes cardiomyocyte and endothelial migration, survival, and repair and may be a novel therapeutic target in the setting of acute myocardial damage.

AB - Heart disease is a leading cause of death in newborns and in adults. Efforts to promote cardiac repair by introduction or recruitment of exogenous stem cells hold promise but typically involve isolation and introduction of autologous or donor progenitor cells. We have found that the G-actin-sequestering peptide thymosin β4 promotes myocardial and endothelial cell migration in the embryonic heart and retains this property in postnatal cardiomyocytes. Survival of embryonic and postnatal cardiomyocytes in culture was also enhanced by thymosin β4. We found that thymosin β4 formed a functional complex with PINCH and integrin-linked kinase (ILK), resulting in activation of the survival kinase Akt/PKB, which was necessary for thymosin β4's effects on cardiomyocytes. After coronary artery ligation in mice, thymosin β4 treatment resulted in upregulation of ILK and Akt activity in the heart, enhanced early myocyte survival, and improved cardiac function. These findings suggest that thymosin β4 promotes cardiomyocyte and endothelial migration, survival, and repair and may be a novel therapeutic target in the setting of acute myocardial damage.

KW - Cardiac repair

KW - Integrin-linked kinase

KW - Thymosin β4

UR - http://www.scopus.com/inward/record.url?scp=35349031022&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35349031022&partnerID=8YFLogxK

U2 - 10.1196/annals.1415.048

DO - 10.1196/annals.1415.048

M3 - Conference contribution

C2 - 17600280

AN - SCOPUS:35349031022

SN - 1573317012

SN - 9781573317016

VL - 1112

T3 - Annals of the New York Academy of Sciences

SP - 161

EP - 170

BT - Annals of the New York Academy of Sciences

ER -